Inhibition of HIV tat–TAR interactions by an antisense oligo-2′-O-methylribonucleoside methylphosphonate
- 2 June 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (11) , 1845-1848
- https://doi.org/10.1016/s0960-894x(03)00323-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Specific HIV-1 TAR RNA Loop Sequence and Functional Groups Are Required for Human Cyclin T1−Tat−TAR Ternary Complex FormationBiochemistry, 2002
- Neomycin B−Arginine Conjugate, a Novel HIV-1 Tat Antagonist: Synthesis and Anti-HIV ActivitiesBiochemistry, 2001
- Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibioticsPublished by Elsevier ,2000
- Syntheses of Alternating Oligo-2‘-O-Methylribonucleoside Methylphosphonates and Their Interactions with HIV TAR RNABiochemistry, 1999
- High Affinity and Specific Binding of HIV-1 TAR RNA by a Tat-Derived OligoureaJournal of the American Chemical Society, 1999
- Taking out TatNature Biotechnology, 1996
- Protein Orientation in the Tat-TAR Complex Determined by Psoralen Photocross-linkingPublished by Elsevier ,1996
- Tetrahydropyrimidine derivatives inhibit binding of a Tat‐like, arginine‐containing peptide, to HIV TAR RNA in vitroFEBS Letters, 1995
- CONTROL OF RNA INITIATION AND ELONGATION AT THE HIV-1 PROMOTERAnnual Review of Biochemistry, 1994
- Pseudo—Half-Knot Formation with RNAScience, 1992